Nitric oxide in health & diseases

Indian Journal of Medical Research

Volumn 125, Issue 6, 2007, Pages 712-714

  Das, R H ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKINE; DOXORUBICIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE DONOR; TIRAPAZAMINE;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; APOPTOSIS; CANCER; CANCER CELL; CELL COMMUNICATION; CLINICAL TRIAL; CYTOTOXICITY; DRUG HALF LIFE; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; HUMAN; HYPOXIA; NONHUMAN; NOTE; OXIDATION REDUCTION REACTION; PHOTODYNAMIC THERAPY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; CALCIUM; CELL COMMUNICATION; FREE RADICALS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN ISOFORMS;

EID: 34548427064     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Note

References (22)

1. Stuehr DJ, Griffith OW. Mammalian nitric oxide synthases. Adv Enzymol Relat Areas Mol Biol 1992; 65: 287-346.
2. Clancy RM, Abramson SB. Nitric oxide: a novel mediator of inflammation. Soc Exp Biol Med 1995; 210: 93-101.
3. Nathan C. Perspectives series: nitric oxide and nitric oxide synthases. Inducible nitric oxide synthase: what difference does it make? J Clin Invest 1997; 41: 7-23.
4. Radomski MW, Palmer RM, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothielial cells. Proc Natl Acad Sci USA 1990; 87: 10043-7.
5. Anstey NM, Weinberg JB, Hassanali MY, Mwaikambo ED, Manyenga D, Misukonis MA, et al. Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide productionjnitric oxide synthase type 2 expression. J Exp Med 1996; 184: 557-67.
6. Chaudhury I, Raghav SK, Gautam HK, Das HR, Das RH. Suppression of inducible nitric-oxide synthase by 10-23 DNAzymes in murine macrophage. FEBS Lett 2006; 580: 2046-52.
7. An AJ, Um JY, Na HJ, Jeong S, Kim HM, Hong SH. Activation of inducible nitric oxide synthase by Kagamjuaguiem in mouse peritoneal macrophages. Indian J Med Res 2007; 125: 740-6.
8. Messmer UK, Lapetina EG, Brune B. Nitric oxide-induced apoptosis in RAW 264.7 macrophages is antagonized by protein kinase C- and protein kinase A-activating compounds. Mol Pharmacol 1995; 47: 757-65.
9. Ankarcrona M, Dypbukt JM, Brune B, Nicotera P. Interleukin-1 beta-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells. Exp Cell Res 1994; 213: 172-7.
10. Blanco FJ, Ochs RL, Schwarz H, Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 1995; 146: 75-85.
11. Fehsel K, Kroncke KD, Meyer KL, Huber H, Wahn V, Kolb-Bachofen V. Nitric oxide induces apoptosis in mouse thymocyths. J Immunol 1995; 155: 2858-65.
12. Mannick JB, Asano K, Izumi K, Kieff E, Stamler JS. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 1994; 79: 1137-46.
13. Dimmeler S, Haendeler J, Nehls M, Zeiher AM. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1b-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J Exp Med 1997; 185: 601-7.
14. Evtushenko VA, Zagrebelnaya GV, Soldatov AN, Kondakova IV, Shumeiko AS. Influence of nitric oxide on antitumor activity of photodynamic therapy: laser systems for PDT. Proc SPIE 2004; 5483: 267-71.
15. Garner AP, Paine MJI, Crespo IR, Chinje EC, Montellano POD, Stratford IJ, et al. Nitric oxide synthases catalyze the activation of redox cycling and bioreductive anticancer agents. Cancer Res 1999; 59: 1929-34.
16. Roberts DD, Isenberg JS, Ridnour LA, Wink DA. Nitric oxide and its gatekeeper thrombospondin-1 in tumor angiogenesis. Clin Cancer Res 2007; 13: 795-8.
17. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-76.
18. Bauskin AR, Alkalay I, Ben-Neriah Y. Redox regulation of a protein tyrosine kinase in the endoplasmic reticulum. Cell 1991; 66: 685-96.
19. 2- and phospholipid-independent activation of protein kinase C by selective oxidative modification of the regulatory domain. Proc Natl Acad Sci USA 1989; 86: 6758-62.
20. Toledamo MB, Leonhard WJ. Modulation of transcription factor NFκB binding by oxidation-reduction in vitro. Proc Natl Acad Sci USA 1991; 88: 4328-32.
21. Nathan C, Sporn M. Minireview: cytokines in context. J Cell Biol 1991; 113: 981-6.
22. Magrinat G, Mason SN, Sahmi PJ, Weinberg JB. Nitric oxide modulation of human leukemia cell differentiation and gene expression. Blood 1992; 80: 1880-4.